Xeris Biopharma Holdings Inc (XERS) last month performance of 11.54% certainly makes it a sizzling prospect
Xeris Biopharma Holdings Inc (NASDAQ: XERS) flaunted slowness of -5.31% at $4.64, as the Stock market unbolted on Wednesday, before settling in for the price